ArticleBMJ open2015

Correction. NILVAD protocol: a European multicenter double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease.

B Lawlor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.